Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Kinetic Analysis of Boron Therapeutics in Head and Neck Cancer Cells by Complementary Bulk ICP-MS and Single-Cell (scICP-MS) Approaches
(Note: The full text of this document is currently only available in the PDF Version )
Jack George Finch , Rhiannon Julie Pass , Maria Rita Fabbrizi , Aimee Elizabeth Patricia McLoughlin , Stuart Green , Jason Luke Parsons and James Paul Charles Coverdale
First published on 14th August 2025
Abstract
Boron neutron capture therapy (BNCT) is an emerging approach to radiotherapy. Neutron capture by a boronated (10B) therapeutic yields high linear energy transfer alpha particles (helium nuclei, 4He) and lithium-7 (7Li) atoms, eliciting a localised cell kill effect. Current methods to quantify boron in cells either infer from circulatory concentrations and/or often overlook rapid boron pharmacokinetics. By considering both sample preparation requirements and biological boron dynamics, we report two novel approaches to quantify intracellular boron: firstly, rapid in situ tryptic and acidic digestion of treated cells to avoid premature B efflux (LOD 10B+ = 0.2 µg⋅L-1, LOD 11B+ = 0.4 µg⋅L-1) with method suitability confirmed by pre- and post-digestion spike recoveries (102.5 ± 0.5% and 103 ± 3% recovery, respectively); secondly, real-time measurement of boron in live cells using single-cell ICP-MS (scICP-MS) revealing real-time monitoring of boron efflux: biological half-life of ca. 6 min. These complementary approaches deliver unprecedented insight into boron influx and efflux and provide essential bioanalytical tools to advance both BNCT therapeutic development and single-cell elemental analysis.